77. Baselga, J., et al., Phase II multicenter study of the antiepidermal growth factor rec eptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum- refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol, 2005. 23(24): p. 5568- 77.